Companies / Nephros Inc

Nephros Inc

Nasdaq: NEPHCIK 1196298SOUTH ORANGE, NJ

Financials · FY2025

Revenue$18.79M
Net income$1.19M
Total debt$571.0K
Cash$4.70M
Diluted EPS$0.11
Shares outstanding10.9M

Ownership

10.9M shares outstanding · as of Aug 7, 2026
3.7%Insiders
Ownership
Insiders3.66%397,317
Institutions48.77%5,296,744
Public float47.57%5,166,059

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 3

View all →
Insider% of sharesShares
Banks Robert R. Jr.CEOPresident and CEO
1.75%190,000
1.27%138,456
Krandel JudyChief Financial Officer
0.63%68,861

Institutional holders 37

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 23, 2026Banks Robert R. Jr.
CEO
ExerciseCommon Stock$172.8K+120K
+171.43%
190,000
1.75% of shares
low
Mar 23, 2026Krandel Judy
Executive
ExerciseCommon Stock$117.8K+69K
68,861
0.63% of shares
low
May 11, 2026Amron Arthur H
Director
GrantCommon Stock$0+4K
+2.65%
138,456
1.27% of shares
low
Mar 16, 2026Amron Arthur H
Director
GrantCommon Stock$0+4K
+2.75%
134,882
1.24% of shares
low
Mar 23, 2026Krandel Judy
Executive
ExerciseStock Option (right to buy)-69K
-56.20%
53,663
0.49% of shares
low
Mar 16, 2026Krandel Judy
Executive
GrantStock Option (right to buy)+4K
4,000
0.04% of shares
low
Mar 23, 2026Banks Robert R. Jr.
CEO
ExerciseStock Option (right to buy)-120K
-33.60%
237,165
2.18% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
NEPHCommon StockEquity640671400BBG000NXRTF2